PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Reliable and more accessible biomarkers along with advanced imaging methods are essential for early diagnosis to achieve effective therapeutic interventions of Alzheimer's disease (AD). In this study, an integrated photoacoustic microscopy (PAM) and optical coherence tomography (OCT) dual-modality ocular biomarkers imaging system was developed, and its performance was evaluated with an Alzheimer's disease mouse model. The beta amyloid deposition in retinal microvasculature were imaging by dual-wavelength PAM with near-infrared absorbing gold nanochains conjugated with anti-beta amyloid antibodies. The multi-layer retinal structure changes were investigated via OCT. With the unique ability of imaging the multiple ocular biomarkers via a single scan, the proposed system provides a new tool for investigating AD in animal models.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.